PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 211 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,850,123 | -66.4% | 64,667 | -65.7% | 0.01% | -65.0% |
| Q1 2024 | $5,506,334 | +119.2% | 188,444 | +153.1% | 0.02% | +100.0% |
| Q4 2023 | $2,512,078 | +138.0% | 74,454 | +116.4% | 0.01% | +100.0% |
| Q3 2023 | $1,055,699 | -76.7% | 34,410 | -57.4% | 0.01% | -82.8% |
| Q3 2021 | $4,528,000 | +117.6% | 80,849 | +135.8% | 0.03% | +107.1% |
| Q2 2021 | $2,081,000 | +679.4% | 34,287 | +800.9% | 0.01% | +600.0% |
| Q1 2021 | $267,000 | -96.1% | 3,806 | -96.7% | 0.00% | -96.5% |
| Q4 2020 | $6,803,000 | +2.4% | 113,692 | +2.9% | 0.06% | +3.6% |
| Q3 2020 | $6,641,000 | +1853.2% | 110,457 | +1370.2% | 0.06% | +685.7% |
| Q4 2019 | $340,000 | -40.0% | 7,513 | -49.6% | 0.01% | -58.8% |
| Q1 2019 | $567,000 | -51.6% | 14,903 | -45.2% | 0.02% | -67.9% |
| Q4 2018 | $1,171,000 | -57.6% | 27,216 | -51.5% | 0.05% | -11.7% |
| Q3 2018 | $2,759,000 | – | 56,126 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
| GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
| Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
| Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
| AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
| ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
| RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
| Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
| Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
| Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |